Physician profile
Tess Dailey
NPI 1225626435
$1,299.74
in general payments reported to CMS, 2019-2025
12 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $154 · 2023: $382 · 2024: $542 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $393.57 | 2023-2025 | Nuzyra, Xhance |
| Smoky Mountain Surgical LLC | $231.47 | 2024-2025 | |
| Inari Medical, INC. | $188.74 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Averitas Pharma INC. | $149.88 | 2023 | Qutenza |
| Amgen INC. | $111.26 | 2022-2024 | Krystexxa |
| Biohaven Pharmaceutical Holding Company LTD. | $71.82 | 2022 | |
| Solventum Corporation | $40.18 | 2025 | Activ.A.C. |
| Djo, LLC | $32.55 | 2024 | Cmf |
| Smith+Nephew, INC. | $28.25 | 2023 | Regranex, Collagenase Santyl |
| Nevro Corp. | $23.68 | 2024 | Senza |
| Ibsa Pharma INC. | $16.70 | 2024 | Licart, Tirosint |
| Bayer Healthcare Pharmaceuticals INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tess Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.